Posted inBusiness Context Therapeutics names Andy Pasternak as chair Posted by admin January 13, 2025No Comments [ad_1] Context Therapeutics names Andy Pasternak as chair [ad_2] admin View All Posts Post navigation Previous Post Arbutus expects to significantly reduce its net cash burn in 2025Next PostDexCom stock rises on 2025 outlook (NASDAQ:DXCM)